Ann: NWR Virtual Healthcare Conference Presentation, page-45

Additionally I am curious why you are so convinced that scientists and doctors would impulsively jump onto bio stocks that they understand the science of with it still being so early and high risk?

I work in cybersecurity and am quite qualified in my field, but don't hold any of the companies whose products I use or know a lot about. Not because they are bad companies, but most of them have low risk and therefore don't present the upside I am chasing. PAR is more my speed. Different risk profile. I imagine the inverse may still be true for the above, they know how risky these investments are this early.

It's a speculative stock despite how far they have come, their whole business likely depends on the success of the next 18 months. That's very high risk, but no where near as risky as 3 years ago. It may feel like its come a long way, but it's risky as.